ReferencesLaSalle, V. H., Cromer, K. R., Nelson, K. N., et al. (2004) Diagnostic interviewassessed neuropsychiatric disorder comorbidity in 334 individuals with obsessivecompulsive disorder. Depression and Anxiety, 19, 163–173.Layard, R. (2006) The Depression Report: a New Deal <strong>for</strong> Depression and AnxietyDisorders. London: Centre <strong>for</strong> Economic Per<strong>for</strong>mance. Available at:http://cep.lse.ac.uk/pubs/download/special/depressionreport.pdfLecrubier, Y., Sheehan, D., Weiller, E., et al. (1997) The MINI InternationalNeuropsychiatric Interview (M.I.N.I.): a short diagnostic structured interview:reliability and validity according to the CIDI. European Psychiatry, 12,224–231.Leon, A. C., Portera, L. & Weissman, M. M. (1995) The social costs of anxiety<strong>disorders</strong>. British Journal of Psychiatry, 166, 19–22.Lewinsohn, P. M., Solomon, A., Seeley, J. R., et al. (2000) Clinical implications of‘subthreshold’ depressive symptoms. Journal of Abnormal Psychology, 109,345–351.Liebowitz, M. R., Gorman, J. M., Fyer, A. J., et al. (1985) Social phobia: review of aneglected anxiety disorder. Archives of General Psychiatry, 42, 729–736.Lindesay, J., Jagger, C., Hibbett, M., et al. (1997) Knowledge, uptake and availabilityof <strong>health</strong> and social services among Asian Gujarati and white elderly persons.Ethnicity and Health, 2, 59–69.Lochner, C. & Stein, D. J. (2003) Heterogeneity of obsessive-compulsive disorder: aliterature review. Harvard Review of Psychiatry, 11, 113–132.Love, A. W., Kissane, D. W., Bloch, S., et al. (2002) Diagnostic efficiency of theHospital Anxiety and Depression Scale in women with early stage breast cancer.Australian and New Zealand Journal of Psychiatry, 36, 246–250.Lowe, B., Spitzer, R. L., Grafe, K., et al. (2004) Comparative validity of threescreening questionnaires <strong>for</strong> DSM-IV depressive <strong>disorders</strong> and physicians’diagnoses. Journal of Affective Disorders, 78, 131–140.Malhi, G. S., Parker, G. B. & Greenwood, J. (2005) Structural and functional modelsof depression: from sub-types to substrates. Acta Psychiatrica Scandinavica, 111,94–105.Mann, J. J., Apter, A., Bertolote, J., et al. (2005) Suicide prevention strategies: asystematic review. Journal of the American Medical Association, 294,2064–2074.Mann, T. (1996) Clinical Guidelines: Using Clinical Guidelines to Improve PatientCare within the NHS. London: Department of Health.Marciniak, M., Lage, M. J., Landbloom, R. P., et al. (2004) Medical and productivitycosts of anxiety <strong>disorders</strong>: case control study. Depression and Anxiety, 19,112–120.Marciniak, M. D., Lage, M. J., Dunayevich, E., et al. (2005) The cost of treatinganxiety: the medical and demographic correlates that impact total medical costs.Depression and Anxiety, 21, 178–184.Marks, I. (1997) Behaviour therapy <strong>for</strong> obsessive-compulsive disorder: a decade ofprogress. Canadian Journal of Psychiatry, 42, 1021–1027.291
ReferencesMarks, J., Goldberg, D. P. & Hillier, V. F. (1979) Determinants of the ability ofgeneral practitioners to detect psychiatric illness. Psychological Medicine, 9,337–353.Marshall, M., Crowther, R., Almaraz-Serrano, A. M., et al. (2001) Systematic reviewsof the effectiveness of day care <strong>for</strong> people with severe <strong>mental</strong> <strong>disorders</strong>: (1) acuteday hospital versus admission; (2) vocational rehabilitation; (3) day hospitalversus outpatient care. Health Technology Assessment, 5, 1–75.McCrone, P., Dhanasiri, S., Patel, A., et al. (2008) Paying the Price: the Cost ofMental Health Care in England to 2026. London: King’s Fund. Available at:http://www.kingsfund.org.uk/publications/paying_the_price.htmlMcManus, S., Meltzer, H., Brugha, T., et al. (2009) Adult Psychiatric Morbidity inEngland, 2007: Results of a Household Survey. Leicester: Department of HealthSciences, University of Leicester.McMillan, D., Gilbody, S., Beres<strong>for</strong>d, E., et al. (2007) Can we predict suicide andnon-fatal self-harm with the Beck Hopelessness Scale? A meta-analysis.Psychological Medicine, 37, 769–778.McNally, R. J. (2003) Remembering Trauma. Cambridge, MA: Harvard UniversityPress.Means-Christensen, A. J., Sherbourne, C. D., Roy-Byrne, P. P., et al. (2006) Usingfive questions to screen <strong>for</strong> five common <strong>mental</strong> <strong>disorders</strong> in primary care:diagnostic accuracy of the Anxiety and Depression Detector. General HospitalPsychiatry, 28, 108–118.Meghani, S. H., Brooks, J. M., Gipson-Jones, T., et al. (2009) Patient-provider raceconcordance:does it matter in improving minority patients’ <strong>health</strong> outcomes?Ethnicity & Health, 14, 107–130.Meltzer, H., Bebbington, P., Brugha, T., et al. (2000) The reluctance to seek treatment<strong>for</strong> neurotic <strong>disorders</strong>. Journal of Mental Health, 9, 319–327.Microsoft (2007) Microsoft Word and Excel [computer software]. Redmond,Washington: Microsoft.Mitchell, A., Vaze, A. & Sanjay Rao, S. (2009) Clinical diagnosis of depression inprimary care: a meta-analysis. Lancet, 374, 609–619.Mitchell, A. J. & Subramaniam, H. (2005) Prognosis of depression in old agecompared to middle age: a systematic review of comparative studies. AmericanJournal of Psychiatry, 162, 1588–1601.Moffat, J., Sass, B., McKenzie, K., et al. (2009) Improving pathways into <strong>mental</strong><strong>health</strong> care <strong>for</strong> black and ethnic minority groups: a systematic review of the greyliterature. International Review of Psychiatry, 21, 439–449.Montgomery, S. A., Kasper, S., Stein, D. J., et al. (2001) Citalopram 20 mg, 40 mgand 60 mg are all effective and well tolerated compared with placebo in obsessivecompulsive disorder. International Clinical Psychopharmacology, 16, 75–86.Moscicki, E. K. (2001) Epidemiology of completed and attempted suicide: toward aframework <strong>for</strong> prevention. Clinical Neuroscience Research, 1, 310–323.Moussavi, S., Chatterji, S., Verdes, E., et al. (2007) Depression, chronic diseases, anddecrements in <strong>health</strong>: results from the World Health Surveys. Lancet, 370,851–858.292
- Page 1 and 2:
Commonmental healthdisordersTHE NIC
- Page 3 and 4:
© The British Psychological Societ
- Page 5 and 6:
Contents6 FURTHER ASSESSMENT OF RIS
- Page 7 and 8:
Guideline development group members
- Page 9 and 10:
Preface1 PREFACEThis guideline has
- Page 11 and 12:
Prefacecollaborative manner using t
- Page 13 and 14:
PrefaceThe experience of people wit
- Page 15 and 16:
Common mental health disorders2.2 T
- Page 17 and 18:
Common mental health disordersto ho
- Page 19 and 20:
Common mental health disordersManua
- Page 21 and 22:
Common mental health disordershighe
- Page 23 and 24:
Common mental health disordersNegat
- Page 25 and 26:
Common mental health disorderscours
- Page 27 and 28:
Common mental health disordersover
- Page 29 and 30:
Common mental health disorders2.2.6
- Page 31 and 32:
Common mental health disordersTable
- Page 33 and 34:
Common mental health disorders1996)
- Page 35 and 36:
Common mental health disordersSumma
- Page 37 and 38:
Common mental health disordersTable
- Page 39 and 40:
Common mental health disordersappli
- Page 41 and 42:
Common mental health disorderspatie
- Page 43 and 44:
Methods used to develop this guidel
- Page 45 and 46:
Methods used to develop this guidel
- Page 47 and 48:
Methods used to develop this guidel
- Page 49 and 50:
Methods used to develop this guidel
- Page 51 and 52:
Methods used to develop this guidel
- Page 53 and 54:
Methods used to develop this guidel
- Page 55 and 56:
Methods used to develop this guidel
- Page 57 and 58:
Methods used to develop this guidel
- Page 59 and 60:
Access to healthcare4. ACCESS TO HE
- Page 61 and 62:
Access to healthcareunder the Menta
- Page 63 and 64:
Access to healthcare4.2.3 Studies c
- Page 65 and 66:
Access to healthcareIndividual-leve
- Page 67 and 68:
Access to healthcareJUNG2003 review
- Page 69 and 70:
Access to healthcareSCHEPPERS2006).
- Page 71 and 72:
Access to healthcare70Table 8: Clin
- Page 73 and 74:
Access to healthcareTable 9: Study
- Page 75 and 76:
Access to healthcareCHAPMAN2004 inc
- Page 77 and 78:
Access to healthcare4.4 SERVICE DEV
- Page 79 and 80:
Access to healthcareBEACH2006 [Beac
- Page 81 and 82:
Access to healthcareTable 12: Summa
- Page 83 and 84:
Access to healthcareAll studies wer
- Page 85 and 86:
Access to healthcarepractitioners h
- Page 87 and 88:
Access to healthcareIndividual-leve
- Page 89 and 90:
Access to healthcarefrom such popul
- Page 91 and 92:
Access to healthcarestructure and d
- Page 93 and 94:
Case identification and formal asse
- Page 95 and 96:
Case identification and formal asse
- Page 97 and 98:
Case identification and formal asse
- Page 99 and 100:
Case identification and formal asse
- Page 101 and 102:
Case identification and formal asse
- Page 103 and 104:
Case identification and formal asse
- Page 105 and 106:
Case identification and formal asse
- Page 107 and 108:
Case identification and formal asse
- Page 109 and 110:
Case identification and formal asse
- Page 111 and 112:
Case identification and formal asse
- Page 113 and 114:
Case identification and formal asse
- Page 115 and 116:
Case identification and formal asse
- Page 117 and 118:
Case identification and formal asse
- Page 119 and 120:
Case identification and formal asse
- Page 121 and 122:
Case identification and formal asse
- Page 123 and 124:
Case identification and formal asse
- Page 125 and 126:
Case identification and formal asse
- Page 127 and 128:
Case identification and formal asse
- Page 129 and 130:
Case identification and formal asse
- Page 131 and 132:
Case identification and formal asse
- Page 133 and 134:
Case identification and formal asse
- Page 135 and 136:
Case identification and formal asse
- Page 137 and 138:
Further assessment of risk and need
- Page 139 and 140:
Further assessment of risk and need
- Page 141 and 142:
Further assessment of risk and need
- Page 143 and 144:
Further assessment of risk and need
- Page 145 and 146:
Further assessment of risk and need
- Page 147 and 148:
Further assessment of risk and need
- Page 149 and 150:
Further assessment of risk and need
- Page 151 and 152:
Further assessment of risk and need
- Page 153 and 154:
Further assessment of risk and need
- Page 155 and 156:
Further assessment of risk and need
- Page 157 and 158:
Further assessment of risk and need
- Page 159 and 160:
Further assessment of risk and need
- Page 161 and 162:
Further assessment of risk and need
- Page 163 and 164:
Further assessment of risk and need
- Page 165 and 166:
Further assessment of risk and need
- Page 167 and 168:
Further assessment of risk and need
- Page 169 and 170:
Further assessment of risk and need
- Page 171 and 172:
Further assessment of risk and need
- Page 173 and 174:
Further assessment of risk and need
- Page 175 and 176:
Further assessment of risk and need
- Page 177 and 178:
Further assessment of risk and need
- Page 179 and 180:
Further assessment of risk and need
- Page 181 and 182:
Further assessment of risk and need
- Page 183 and 184:
Further assessment of risk and need
- Page 185 and 186:
Further assessment of risk and need
- Page 187 and 188:
Further assessment of risk and need
- Page 189 and 190:
Systems for organising and developi
- Page 191 and 192:
Systems for organising and developi
- Page 193 and 194:
Systems for organising and developi
- Page 195 and 196:
Systems for organising and developi
- Page 197 and 198:
Systems for organising and developi
- Page 199 and 200:
Systems for organising and developi
- Page 201 and 202:
Systems for organising and developi
- Page 203 and 204:
Systems for organising and developi
- Page 205 and 206:
Systems for organising and developi
- Page 207 and 208:
Systems for organising and developi
- Page 209 and 210:
Systems for organising and developi
- Page 211 and 212:
Systems for organising and developi
- Page 213 and 214:
Systems for organising and developi
- Page 215 and 216:
Systems for organising and developi
- Page 217 and 218:
Summary of recommendations8.1.1.6 S
- Page 219 and 220:
Summary of recommendationsFigure 12
- Page 221 and 222:
Summary of recommendations●Genera
- Page 223 and 224:
Summary of recommendations8.4 STEPS
- Page 225 and 226:
Summary of recommendations●●a g
- Page 227 and 228:
Summary of recommendationsDiscuss w
- Page 229 and 230:
Summary of recommendationsinclude p
- Page 231 and 232:
Appendices9 APPENDICESAppendix 1: S
- Page 233 and 234:
Appendix 1of a depressive disorder
- Page 235 and 236:
Appendix 1b) Assessment of anxiety
- Page 237 and 238:
Appendix 2APPENDIX 2:DECLARATIONS O
- Page 239 and 240:
Appendix 2Mr Mike BessantEmployment
- Page 241 and 242: Appendix 2Personal non-pecuniary in
- Page 243 and 244: Appendix 2Actions takenMr Rupert Su
- Page 245 and 246: Appendix 2Personal family interestN
- Page 247 and 248: Appendix 3APPENDIX 3:STAKEHOLDERS A
- Page 249 and 250: Appendix 4ClinicalpopulationPeople
- Page 251 and 252: Appendix 4Case identificationNo. Pr
- Page 253 and 254: Appendix 5APPENDIX 5:REVIEW PROTOCO
- Page 255 and 256: Appendix 7APPENDIX 7:METHODOLOGY CH
- Page 257 and 258: Appendix 9APPENDIX 9:METHODOLOGY CH
- Page 259 and 260: Appendix 92.10 Are all important pa
- Page 261 and 262: Appendix 9case also excludes costs
- Page 263 and 264: Appendix 9For consistency, the EQ-5
- Page 265 and 266: Appendix 9Answer ‘yes’ if the a
- Page 267 and 268: Appendix 9Answer ‘yes’ if the e
- Page 269 and 270: Appendix 9Answer ‘yes’ if appro
- Page 271 and 272: Appendix 10APPENDIX 10: EVIDENCE TA
- Page 273 and 274: Appendix 11APPENDIX 11:HIGH PRIORIT
- Page 275 and 276: Appendix 11discussion of options bu
- Page 277 and 278: Appendix 13APPENDIX 13:GENERALIZED
- Page 279 and 280: ReferencesAndlin-Sobocki, P., Jöns
- Page 281 and 282: ReferencesBower, P., Gilbody, S., R
- Page 283 and 284: ReferencesCooper, S., Smiley, E., M
- Page 285 and 286: ReferencesEhlers A., Gene-Cos N. &
- Page 287 and 288: ReferencesGiles, D. E., Jarrett, R.
- Page 289 and 290: ReferencesHorowitz, M. J., Wilner,
- Page 291: ReferencesKnapp, M. & Ilson, S. (20
- Page 295 and 296: ReferencesNCCMH (forthcoming) Self-
- Page 297 and 298: ReferencesOzer, E. J., Best, S. R.,
- Page 299 and 300: ReferencesSartorius, N. (2002) Eine
- Page 301 and 302: ReferencesTiemens, B. G., Ormel, J.
- Page 303 and 304: ReferencesWilkinson, M. J. B. & Bar
- Page 305 and 306: Glossarybeliefs and interpretations
- Page 307 and 308: Glossaryto learn to become more awa
- Page 309 and 310: Abbreviations12 ABBREVIATIONSADDADS
- Page 311 and 312: AbbreviationsOASISOCDONSORPHQ (-A,